<DOC>
	<DOCNO>NCT01998399</DOCNO>
	<brief_summary>The purpose study determine drug ticagrelor effective treatment patient severe community acquire pneumonia . The primary objective reduce all-cause mortality ticagrelor group compare placebo group .</brief_summary>
	<brief_title>Ticagrelor Severe Community Acquired Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>1 . Patients new `` severe '' CAP define . New ( within 72 hour hospital admission ) radiographic find consistent pneumonia admission plan admission ICU : . Mechanical Ventilation ( invasive noninvasive ) OR ii . Vasopressors ( dobutamine phosphodiesterase consider vasopressor criterion ) OR iii . ICU admission due severe respiratory distress arterial desaturation . b . At least two follow ; i. recent increase dyspnea ii . increase sputum production iii . change character sputum iv . White Blood Cells &gt; 12,000 &lt; 4,000 cells/mm3 &gt; 10 % band v. Body temperature &gt; 38ºC &lt; 36ºC ( route ) 1 . More 72 hour pass since meeting require inclusion criterion . 2 . Development pneumonia 72 hour current hospitalization . 3 . Underlying disease likely cause mortality within 90 day randomization . 4 . A resident hospital , nursing home , within 30 day prior development pneumonia . 5 . Patients moribund ( expect live 48 hour ) . 6 . No consent/inability obtain consent patient surrogate . 7 . Patient 's physician unwilling patient enter study . 8 . Age le 50 year . 9 . Pregnancy . 10 . Breast feeding . 11 . Underlying immunodeficiency ( e.g . HIV , neutropenia , active hematologic malignancy , functional anatomical asplenia hypogammaglobulinemia ) . 12 . Patient , surrogate , physician commit full support ( exception : patient exclude he/she receive supportive care except attempt resuscitation cardiac arrest ) . 13 . Unable receive unlikely absorb enteral study drug ( e.g. , patient partial complete mechanical bowel obstruction , intestinal ischemia , infarction , short bowel syndrome ) . 14 . Hepatic impairment . Child Pugh score &gt; 7 use data outpatient set 15 . Conditions increase risk bleeding , e.g . : 1 . Surgery likely need surgery study , evidence active bleeding postoperatively ( ICU procedures line placement , tracheostomy chest tube consider exclusion ) ; 2 . A history severe head trauma require hospitalization intracranial surgery within 3 month ; 3 . Any history intracerebral arteriovenous malformation , cerebral aneurysm , mass lesion central nervous system , hemorrhagic stroke intracranial hemorrhage , congenital bleeding diathesis ; 4 . Gastrointestinal bleeding within 6 week study unless corrective procedure perform ; 5 . Recent trauma consider increase risk bleed . 16 . Chronic renal disease require renal replacement therapy . 17 . Creatinine &gt; 3 mg/dL . 18 . Platelet count &lt; 50,000 /mm3 . 19 . Use P2Y12 inhibitor within 3 month prior randomization physician intent initiate one CYP3A inhibitor , e.g . ketoconazole , itraconazole , voriconazole , clarithromycin , nefazodone , ritonavir , atazanovir , saquinavir , nelfinavir , indinavir , telithromycin . 20 . Use CYP3A inducer , e.g . rifampin , phenytoin , carbamazepine phenobarbital . 21 . Simvastatin Lovastatin dose &gt; 40 mg per day . 22 . Digoxin use . 23 . Receiving aspirin physician and/or patient unwilling reduce aspirin dose &lt; 100 mg per day . 24 . Daily Nonsteroidal antiinflammatory drug ( NSAID ) use outpatient ( Aspirin ( ASA ) ) . 25 . Sick Sinus Syndrome , 2nd 3rd degree heart block , bradycardia induce syncope unless pacemaker place . 26 . Otherwise unsuitable participation opinion investigator ( i.e. , homeless , noncompliant , etc . ) .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>CAP</keyword>
	<keyword>Pneumonia</keyword>
	<keyword>Intensive Care Unit</keyword>
	<keyword>Mechanical Ventilation</keyword>
</DOC>